Why RUO Antibodies Matter in Process Development
Process development is the bridge between early discovery and clinical manufacturing. At this critical stage, teams must characterize molecules, monitor quality, and establish reproducible assays that will scale into regulated environments. Reliable antibodies are central to this work.
ProSci’s Research Use Only (RUO) antibodies, available through both our extensive catalog and custom antibody development services, empower process development teams with precision tools to evaluate biologics. With more than 27 years of expertise, we provide antibodies designed to meet the unique demands of critical quality attributes (CQAs), CMC batch release, PK assays, potency testing, and advanced biologics analytics.
RUO Antibodies Across Process Development Workflows
- Critical Quality Attributes (CQA) & CMC Batch Release
- Challenge: Ensuring lot-to-lot consistency and regulatory readiness.
- Solution: RUO antibodies detect product- and process-related impurities including host cell proteins (HCPs), glycosylation variants, and aggregation markers.
- Impact: Supports comparability studies and reliable CMC batch release decisions.
- Pharmacokinetics (PK) & ADA Monitoring
- Anti-idiotype antibodies provide precise measurement of therapeutic drug levels.
- Distinguish therapeutic antibodies from endogenous immunoglobulins.
- Enable development of bridging PK assays and monitoring of anti-drug antibodies (ADA) to inform dose optimization and safety.
- Potency Assays
- Potency is central to regulatory acceptance of biologics.
- RUO antibodies support both cell-based and biochemical assays to demonstrate functional activity.
- Fc effector function antibodies (e.g., ADCC, CDC reporters) enable evaluation of immune mechanisms of action.
- Anti-Payload Antibodies for ADC Development
- Antibody–drug conjugates (ADCs) demand specialized tools.
- Custom anti-payload antibodies enable detection of free vs conjugated drug, ensuring linker stability and payload release monitoring.
- Critical for quality control and safety profiling in ADC pipelines.
- Supporting Advanced Biologics Characterization
RUO antibodies go beyond basic detection:
- Phospho-specific antibodies identify signaling pathways and PTMs.
- Recombinant monoclonals deliver lot-to-lot reproducibility for long-term process development studies.
- Custom polyclonals offer broader reactivity for complex assay needs.
Why Choose RUO Antibodies for Process Development?
- Rapid Availability: Faster timelines than GMP reagents, allowing quick iteration.
- Scalable Solutions: RUO assays can be validated and transitioned into regulated workflows.
- Tailored Fit: Custom RUO antibodies ensure specificity for your therapeutic, target, or payload.
- Trusted Partner: ProSci works as an extension of your team—helping ensure your assays are fit for purpose.
ProSci’s RUO Antibody Solutions
- Catalog Antibodies: Ready-to-use reagents for common targets in biologics development.
- Custom Antibody Services: Polyclonal, monoclonal, recombinant, and anti-idiotype development tailored to your therapeutic program.
- Expertise Across Therapeutic Modalities: Supporting monoclonal antibodies, bispecifics, ADCs, vaccines, and more.
Browse our catalog antibodies
Explore custom antibody services
Building Confidence in Your Process Development Assays
From discovery through scale-up, RUO antibodies remain a cornerstone of biologics process development. Whether you need to monitor CQAs, design PK assays, evaluate potency, or characterize ADC payloads, ProSci’s catalog and custom antibody solutions give you the tools to move forward with confidence.
Trusted antibodies. Personal care. That’s the ProSci difference.
Why RUO Antibodies Matter in Process Development